MEDLINE EXCEL WHEELCHAIRS

K990463 · Medline · IOR · Mar 15, 1999 · Physical Medicine

Device Facts

Record IDK990463
Device NameMEDLINE EXCEL WHEELCHAIRS
ApplicantMedline
Product CodeIOR · Physical Medicine
Decision DateMar 15, 1999
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 890.3850
Device ClassClass 1
AttributesTherapeutic

Intended Use

Medline Excel Wheelchairs are intended to be used to provide mobility to persons restricted to a sitting position.

Device Story

Medline Excel Wheelchairs provide mobility for individuals restricted to a sitting position. Device functions as a manual wheelchair; operated by the patient or an attendant. Used in clinical, home, or community settings to facilitate transport and independence. Output is physical mobility; healthcare providers use device to assist patients with limited ambulatory capacity. Benefits include improved patient mobility and quality of life.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Manual wheelchair design; materials and construction consistent with standard mobility aid specifications. No electronic components, software, or energy sources.

Indications for Use

Indicated for persons restricted to a sitting position requiring mobility assistance.

Regulatory Classification

Identification

A mechanical wheelchair is a manually operated device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three lines representing its body and wings. The eagle is facing right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAR 1 5 1999 Ms. Lara N. Simmons Corporate Director, Regulatory Affairs Medline Industries, Inc. One Medline Place Mundelein, Illinois 60060-4486 K990463 Re: Medline Excel Wheelchairs Trade Name: Requlatory Class: ने Product Code: IOR August 5, 1998 Dated: February 12, 1999 Received: Dear Ms. Simmons: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {1}------------------------------------------------ ## Page 2 - Ms. Lara N. Simmons This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## INTENDED USE 510(k) Number (if known): (N/A) Device Name: Medline Excel Wheelchairs Indications for Use: Medline Excel Wheelchairs are intended to be used to provide mobility to persons restricted to a sitting position. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use $$\not\exists$$ (Optional Format 1-2-96) Pcsellle (Division Sign ai Restorative Devices Division of Ge 510(k) Number
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%